Human norovirus hyper-mutation revealed by ultra-deep sequencing

Infection, Genetics and Evolution

Volumn 41, Issue , 2016, Pages 233-239

  Cuevas, José M ^a   Combe, Marine ^a   Torres Puente, Manoli ^b   Garijo, Raquel ^a   Guix, Susana ^c   Buesa, Javier ^d   Rodríguez Díaz, Jesús ^d   Sanjuán, Rafael ^a,d  

^a UNIVERSITY OF VALENCIA   (Spain)

^b Fundacion para el Fomento de la Investigacion Sanitaria y Biomedica de la Comunitat Valenciana   (Spain)

^c UNIVERSITY OF BARCELONA   (Spain)

^d UNIVERSITY OF VALENCIA   (Spain)

Author keywords

Hyper mutation; Next generation sequencing; Norovirus; RNA virus

Indexed keywords

ARTICLE; CONTROLLED STUDY; DNA SEQUENCE; EMBRYO; HUMAN; HUMAN CELL; MUTATION RATE; NONHUMAN; NOROVIRUS; NOROVIRUS INFECTION; NUCLEOTIDE SEQUENCE; PRIORITY JOURNAL; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; RNA EDITING; SEQUENCE ANALYSIS; UNINDEXED SEQUENCE; VIRUS CAPSID; VIRUS MUTATION; VIRUS REPLICATION; CALICIVIRUS INFECTION; FECES; GASTROENTERITIS; GENE EXPRESSION; GENETIC TRANSFECTION; GENETICS; GROWTH, DEVELOPMENT AND AGING; HEK293 CELL LINE; HIGH THROUGHPUT SEQUENCING; ISOLATION AND PURIFICATION; MOLECULAR CLONING; VIROLOGY;

VIRAL PROTEIN; VIRUS RNA;

BASE SEQUENCE; CALICIVIRIDAE INFECTIONS; CLONING, MOLECULAR; FECES; GASTROENTERITIS; GENE EXPRESSION; HEK293 CELLS; HIGH-THROUGHPUT NUCLEOTIDE SEQUENCING; HUMANS; MUTATION RATE; NOROVIRUS; RNA, VIRAL; TRANSFECTION; VIRAL PROTEINS; VIRUS REPLICATION;

EID: 84963820503     PISSN: 15671348     EISSN: 15677257     Source Type: Journal    
DOI: 10.1016/j.meegid.2016.04.017     Document Type: Article

References (56)

1. Asanaka M., Atmar R.L., Ruvolo V., Crawford S.E., Neill F.H., Estes M.K. Replication and packaging of Norwalk virus RNA in cultured mammalian cells. Proc. Natl. Acad. Sci. U. S. A. 2005, 102:10327-10332.
2. Bodhidatta L., Abente E., Neesanant P., Nakjarung K., Sirichote P., Bunyarakyothin G., Vithayasai N., Mason C.J. Molecular epidemiology and genotype distribution of noroviruses in children in Thailand from 2004 to 2010: a multi-site study. J. Med. Virol. 2015, 87:664-674.
3. Bull R.A., White P.A. Mechanisms of GII.4 norovirus evolution. Trends Microbiol. 2011, 19:233-240.
4. Camacho C., Coulouris G., Avagyan V., Ma N., Papadopoulos J., Bealer K., Madden T.L. BLAST+: architecture and applications. BMC Bioinformatics 2009, 10. 421-10.
5. Carlsson B., Lindberg A.M., Rodriguez-Diaz J., Hedlund K.O., Persson B., Svensson L. Quasispecies dynamics and molecular evolution of human norovirus capsid P region during chronic infection. J. Gen. Virol. 2009, 90:432-441.
6. Cattaneo R., Schmid A., Eschle D., Baczko K., ter Meulen V., MA B. Biased hypermutation and other genetic changes in defective measles viruses in human brain infections. Cell 1988, 55:255-265.
7. Cotten M., Petrova V., Phan M.V., Rabaa M.A., Watson S.J., Ong S.H., Kellam P., Baker S. Deep sequencing of norovirus genomes defines evolutionary patterns in an urban tropical setting. J. Virol. 2014, 88:11056-11069.
8. Cuevas J.M., Geller R., Garijo R., López-Aldeguer J., Sanjuán R. Extremely high mutation rate of HIV-1 in vivo. PLoS Biol. 2015, 13.
9. Dawson T.R., Sansam C.L., Emeson R.B. Structure and sequence determinants required for the RNA editing of ADAR2 substrates. J. Biol. Chem. 2004, 279:4941-4951.
10. Debbink K., Lindesmith L.C., Donaldson E.F., Baric R.S. Norovirus immunity and the great escape. PLoS Pathog. 2012, 8.
11. Desimmie B.A., Delviks-Frankenberrry K.A., Burdick R.C., Qi D., Izumi T., Pathak V.K. Multiple APOBEC3 restriction factors for HIV-1 and one Vif to rule them all. J. Mol. Biol. 2014, 426:1220-1245.
12. Dingle K.E. Mutation in a Lordsdale norovirus epidemic strain as a potential indicator of transmission routes. J. Clin. Microbiol. 2004, 42:3950-3957.
13. Donaldson E.F., Lindesmith L.C., Lobue A.D., Baric R.S. Viral shape-shifting: norovirus evasion of the human immune system. Nat. Rev. Microbiol. 2010, 8:231-241.
14. George C.X., Gan Z., Liu Y., Samuel C.E. Adenosine deaminases acting on RNA, RNA editing, and interferon action. J. Interf. Cytokine Res. 2011, 31:99-117.
15. Ho Y.C., Shan L., Hosmane N.N., Wang J., Laskey S.B., Rosenbloom D.I., Lai J., Blankson J.N., Siliciano J.D., Siliciano R.F. Replication-competent noninduced proviruses in the latent reservoir increase barrier to HIV-1 cure. Cell 2013, 155:540-551.
16. Holzknecht B.J., Franck K.T., Nielsen R.T., Bottiger B., Fischer T.K., Fonager J. Sequence analysis of the capsid gene during a genotype II.4 dominated norovirus season in one university hospital: identification of possible transmission routes. PLoS One 2015, 10.
17. Jones M.K., Watanabe M., Zhu S., et al. Enteric bacteria promote human and mouse norovirus infection of B cells. Science 2014, 346:755-759.
18. Jünemann S., Sedlazeck F.J., Prior K., Albersmeier A., John U., Kalinowski J., Mellmann A., Goesmann A., von Haeseler A., Stoye J., Harmsen D. Updating benchtop sequencing performance comparison. Nat. Biotechnol. 2013, 31:294-296.
19. Katayama K., Murakami K., Sharp T.M., Guix S., Oka T., Takai-Todaka R., Nakanishi A., Crawford S.E., Atmar R.L., Estes M.K. Plasmid-based human norovirus reverse genetics system produces reporter-tagged progeny virus containing infectious genomic RNA. Proc. Natl. Acad. Sci. U. S. A. 2014, 111:E4043-E4052.
20. Kim U., Wang Y., Sanford T., Zeng Y., Nishikura K. Molecular cloning of cDNA for double-stranded RNA adenosine deaminase, a candidate enzyme for nuclear RNA editing. Proc. Natl. Acad. Sci. U. S. A. 1994, 91:11457-11461.
21. Kobayashi M., Yoshizumi S., Kogawa S., et al. Molecular evolution of the capsid gene in norovirus genogroup I. Sci. Rep. 2015, 5:13806.
22. Koboldt D.C., Larson D.E., Wilson R.K. Using VarScan 2 for germline variant calling and somatic mutation detection. Curr. Protoc. Bioinformatics 2013, 44:15.
23. Kuttan A., Bass B.L. Mechanistic insights into editing-site specificity of ADARs. Proc. Natl. Acad. Sci. U. S. A. 2012, 109:E3295-E3304.
24. Lauring A.S., Frydman J., Andino R. The role of mutational robustness in RNA virus evolution. Nat. Rev. Microbiol. 2013, 11:327-336.
25. Lehmann K.A., Bass B.L. Double-stranded RNA adenosine deaminases ADAR1 and ADAR2 have overlapping specificities. Biochemistry 2000, 39:12875-12884.
26. Li H., Handsaker B., Wysoker A., Fennell T., Ruan J., Homer N., Marth G., Abecasis G., Durbin R. The sequence alignment/map format and SAMtools. Bioinformatics 2009, 25:2078-2079.
27. Lindesmith L.C., Donaldson E.F., Lobue A.D., Cannon J.L., Zheng D.P., Vinje J., Baric R.S. Mechanisms of GII.4 norovirus persistence in human populations. PLoS Med 2008, 5.
28. Marcel M. Cutadapt Removes Adapter Sequences From High-throughput Sequencing Reads 2011, 17:10-12. EMBnet J.
29. Martínez I., Melero J.A. A model for the generation of multiple A to G transitions in the human respiratory syncytial virus genome: predicted RNA secondary structures as substrates for adenosine deaminases that act on RNA. J. Gen. Virol. 2002, 83:1445-1455.
30. Masella A.P., Bartram A.K., Truszkowski J.M., Brown D.G., Neufeld J.D. PANDAseq: paired-end assembler for illumina sequences. BMC Bioinformatics 2012, 13. 31-13.
31. Moris A., Murray S., Cardinaud S. AID and APOBECs span the gap between innate and adaptive immunity. Front. Microbiol. 2014, 5:534.
32. Murphy D.G., Dimock K., Kang C.Y. Numerous transitions in human parainfluenza virus 3 RNA recovered from persistently infected cells. Virology 1991, 181:760-763.
33. Nilsson M., Hedlund K.O., Thorhagen M., Larson G., Johansen K., Ekspong A., Svensson L. Evolution of human calicivirus RNA in vivo: accumulation of mutations in the protruding P2 domain of the capsid leads to structural changes and possibly a new phenotype. J. Virol. 2003, 77:13117-13124.
34. Obara M., Hasegawa S., Iwai M., Horimoto E., Nakamura K., Kurata T., Saito N., Oe H., Takizawa T. Single base substitutions in the capsid region of the norovirus genome during viral shedding in cases of infection in areas where norovirus infection is endemic. J. Clin. Microbiol. 2008, 46:3397-3403.
35. Patel M.M., Widdowson M.A., Glass R.I., Akazawa K., Vinje J., Parashar U.D. Systematic literature review of role of noroviruses in sporadic gastroenteritis. Emerg. Infect. Dis. 2008, 14:1224-1231.
36. Polson A.G., Bass B.L. Preferential selection of adenosines for modification by double-stranded RNA adenosine deaminase. EMBO J. 1994, 13:5701-5711.
37. Robilotti E., Deresinski S., Pinsky B.A. Norovirus. Clin. Microbiol. Rev. 2015, 28:134-164.
38. Russell R.A., Moore M.D., Hu W.S., Pathak V.K. APOBEC3G induces a hypermutation gradient: purifying selection at multiple steps during HIV-1 replication results in levels of G-to-A mutations that are high in DNA, intermediate in cellular viral RNA, and low in virion RNA. Retrovirology 2009, 6:16.
39. Samuel C.E. Adenosine deaminases acting on RNA (ADARs) are both antiviral and proviral. Virology 2011, 411:180-193.
40. Sanjuán R., Nebot M.R., Chirico N., Mansky L.M., Belshaw R. Viral mutation rates. J. Virol. 2010, 84:9733-9748.
41. Santa-Marta M., de Brito P.M., Godinho-Santos A., Goncalves J. Host factors and HIV-1 replication: clinical evidence and potential therapeutic approaches. Front. Immunol. 2013, 4:343.
42. Sasaki Y., Kai A., Hayashi Y., et al. Multiple viral infections and genomic divergence among noroviruses during an outbreak of acute gastroenteritis. J. Clin. Microbiol. 2006, 44:790-797.
43. Sato S., Wong S.K., Lazinski D.W. Hepatitis delta virus minimal substrates competent for editing by ADAR1 and ADAR2. J. Virol. 2001, 75:8547-8555.
44. Schmieder R., Edwards R. Quality control and preprocessing of metagenomic datasets. Bioinformatics 2011, 27:863-864.
45. Smith E.C., Denison M.R. Coronaviruses as DNA wannabes: a new model for the regulation of RNA virus replication fidelity. PLoS Pathog. 2013, 9.
46. Suspène R., Guetard D., Henry M., Sommer P., Wain-Hobson S., Vartanian J.P. Extensive editing of both hepatitis B virus DNA strands by APOBEC3 cytidine deaminases in vitro and in vivo. Proc. Natl. Acad. Sci. U. S. A. 2005, 102:8321-8326.
47. Suspène R., Renard M., Henry M., Guetard D., Puyraimond-Zemmour D., Billecocq A., Bouloy M., Tangy F., Vartanian J.P., Wain-Hobson S. Inversing the natural hydrogen bonding rule to selectively amplify GC-rich ADAR-edited RNAs. Nucleic Acids Res. 2008, 36.
48. Suspène R., Aynaud M.M., Koch S., Pasdeloup D., Labetoulle M., Gaertner B., Vartanian J.P., Meyerhans A., Wain-Hobson S. Genetic editing of herpes simplex virus 1 and Epstein-Barr herpesvirus genomes by human APOBEC3 cytidine deaminases in culture and in vivo. J. Virol. 2011, 85:7594-7602.
49. Ulferts R., Ziebuhr J. Nidovirus ribonucleases: structures and functions in viral replication. RNA Biol. 2011, 8:295-304.
50. Valente L., Nishikura K. ADAR gene family and A-to-I RNA editing: diverse roles in posttranscriptional gene regulation. Prog. Nucleic Acid Res. Mol. Biol. 2005, 79:299-338.
51. Vartanian J.P., Guetard D., Henry M., Wain-Hobson S. Evidence for editing of human papillomavirus DNA by APOBEC3 in benign and precancerous lesions. Science 2008, 320:230-233.
52. Vega E., Donaldson E., Huynh J., Barclay L., Lopman B., Baric R., Chen L.F., Vinje J. RNA populations in immunocompromised patients as reservoirs for novel norovirus variants. J. Virol. 2014, 88:14184-14196.
53. Wang I.X., So E., Devlin J.L., Zhao Y., Wu M., Cheung V.G. ADAR regulates RNA editing, transcript stability, and gene expression. Cell Rep. 2013, 5:849-860.
54. White P.A. Evolution of norovirus. Clin. Microbiol. Infect. 2014, 20:741-745.
55. Zahn R.C., Schelp I., Utermohlen O., LD v. A-to-G hypermutation in the genome of lymphocytic choriomeningitis virus. J. Virol. 2007, 81:457-464.
56. Zuker M. Mfold web server for nucleic acid folding and hybridization prediction. Nucleic Acids Res. 2003, 31:3406-3415.